ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$169.17
*  
3.10
1.8%
Get ALXN Alerts
*Delayed - data as of Aug. 27, 2014  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
8/27/2014 10:32:00 AM - Zacks.com

5 Rocket Stocks to Buy for S&P 2,000
8/25/2014 11:36:00 AM - TheStreet

Alexion Initiates Registration Trial Of Eculizumab To Prevent DGF
8/25/2014 6:54:00 AM - RTT News

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha

Cramer's Mad Money - 12 Stocks That Have Performed Better Than Google (8/21/14)
8/22/2014 6:22:00 AM - Seeking Alpha

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog
8/20/2014 11:08:00 AM - Zacks.com

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
8/19/2014 5:25:00 PM - Zacks.com

12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds
8/10/2014 10:54:00 AM - Seeking Alpha

Alnylam Pharmaceuticals Has Plenty On Its Plate
8/9/2014 10:36:00 AM - Seeking Alpha

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
8/8/2014 11:00:00 AM - Zacks.com

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 9:20:00 AM - Zacks.com

NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog
8/7/2014 12:40:00 PM - Zacks.com

Vertex's Price And Prospects Compared To Alexion
8/7/2014 10:50:00 AM - Seeking Alpha

Noteworthy ETF Inflows: TQQQ, ATVI, AKAM, ALXN
8/6/2014 10:49:53 AM - BNK Invest

Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog
8/5/2014 2:00:00 PM - Zacks.com

Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
8/4/2014 3:40:00 PM - Zacks.com

Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog
8/4/2014 11:10:00 AM - Zacks.com

Dr. Reddy's (RDY) Q1 Earnings and Revenues Rise Y/Y - Analyst Blog
8/1/2014 3:20:00 PM - Zacks.com

Alexion : EC Grants Orphan Drug Designation To Soliris To Treat Patients With MG
8/1/2014 6:39:00 AM - RTT News

Aegerion Q2 Loss Narrower than Expected, 2014 View Retained - Analyst Blog
7/30/2014 3:15:00 PM - Zacks.com

Biotech ETF Price Swings May Signal Need For Caution
7/28/2014 6:03:00 PM - Investor's Business Daily

Nasdaq 100 Movers: MNST, DLTR
7/28/2014 11:41:13 AM - BNK Invest

Alexion Looks Better After Q2 Earnings
7/28/2014 10:40:00 AM - Seeking Alpha

Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
7/24/2014 3:45:00 PM - Zacks.com

Alexion Pharmaceuticals Q2 14 Earnings Conference Call At 10:00 AM ET
7/24/2014 9:01:00 AM - RTT News